Hong Kong’s Exchange Improves Its Allure for Chinese Issuers

Published date29 January 2021
Subject MatterBiotechnology,Hong Kong,Foreign Relations,Hong Kong Stock Exchange,PCAOB,Publicly-Traded Companies,Initial Public Offerings,Capital Raising,Capital Markets,China,HKEx,SEC
AuthorChristopher Betts,Paloma Wang
Law FirmSkadden, Arps, Slate, Meagher & Flom LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT